Literature DB >> 23627757

Vascular risk factors and neurodegeneration in ageing related dementias: Alzheimer's disease and vascular dementia.

Rufus O Akinyemi1, Elizabeta B Mukaetova-Ladinska, Johannes Attems, Masafumi Ihara, Raj N Kalaria.   

Abstract

Age is the strongest risk factor for brain degeneration whether it results from vascular or neurodegenerative mechanisms or both. To evaluate the current views on the impact of vascular disease on the most common causes of dementia, most relevant articles to the selected subject headings were reviewed until November 2011 from the popularly used databases including Pubmed, Cochrane Database and Biological Abstracts. Within the past decade, there has been four-fold increased interest in the vascular basis of neurodegeneration and dementia. Vascular ageing involving arterial stiffness, endothelial changes and blood-brain barrier dysfunction affects neuronal survival by impairing several intracellular protective mechanisms leading to chronic hypoperfusion. Modifiable risk factors such as hypertension, diabetes, dyslipidaemia and adiposity linked to Alzheimer's disease and vascular dementia promote the degeneration and reduce the regenerative capacity of the vascular system. These in tandem with accumulation of abnormal proteins such as amyloid β likely disrupt cerebral autoregulation, neurovascular coupling and perfusion of the deeper structures to variable degrees to produce white matter changes and selective brain atrophy. Brain pathological changes may be further modified by genetic factors such as the apoliopoprotein E ε4 allele. Lifestyle measures that maintain or improve vascular health including consumption of healthy diets, moderate use of alcohol and implementing regular physical exercise in general appear effective for reducing dementia risk. Interventions that improve vascular function are important to sustain cognitive status even during ageing whereas preventative measures that reduce risk of vascular disease are predicted to lessen the burden of dementia in the long-term.

Entities:  

Mesh:

Year:  2013        PMID: 23627757     DOI: 10.2174/15672050113109990037

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  63 in total

Review 1.  Cerebrovascular contributions to aging and Alzheimer's disease in Down syndrome.

Authors:  Donna M Wilcock; Frederick A Schmitt; Elizabeth Head
Journal:  Biochim Biophys Acta       Date:  2015-11-26

2.  Astrocytic changes with aging and Alzheimer's disease-type pathology in chimpanzees.

Authors:  Emily L Munger; Melissa K Edler; William D Hopkins; John J Ely; Joseph M Erwin; Daniel P Perl; Elliott J Mufson; Patrick R Hof; Chet C Sherwood; Mary Ann Raghanti
Journal:  J Comp Neurol       Date:  2019-01-07       Impact factor: 3.215

3.  The neuroprotection of repetitive transcranial magnetic stimulation pre-treatment in vascular dementia rats.

Authors:  Fei Wang; Guang-ming Chang; Qian Yu; Xin Geng
Journal:  J Mol Neurosci       Date:  2015-01-14       Impact factor: 3.444

4.  Total Brain and Hippocampal Volumes and Cognition in Older American Indians: The Strong Heart Study.

Authors:  Brenna Cholerton; Adam Omidpanah; Tara M Madhyastha; Thomas J Grabowski; Astrid M Suchy-Dicey; Dean K Shibata; Lonnie A Nelson; Steven P Verney; Barbara V Howard; William T Longstreth; Thomas J Montine; Dedra Buchwald
Journal:  Alzheimer Dis Assoc Disord       Date:  2017 Apr-Jun       Impact factor: 2.703

Review 5.  Stroke, cerebrovascular diseases and vascular cognitive impairment in Africa.

Authors:  Rufus O Akinyemi; Mayowa O Owolabi; Masafumi Ihara; Albertino Damasceno; Adesola Ogunniyi; Catherine Dotchin; Stella-Maria Paddick; Julius Ogeng'o; Richard Walker; Raj N Kalaria
Journal:  Brain Res Bull       Date:  2018-05-25       Impact factor: 4.077

6.  Sex-specific relationship of cardiometabolic syndrome with lower cortical thickness.

Authors:  Si Eun Kim; Jin San Lee; Sookyoung Woo; Seonwoo Kim; Hee Jin Kim; Seongbeom Park; Byung In Lee; Jinse Park; Yeshin Kim; Hyemin Jang; Seung Joo Kim; Soo Hyun Cho; Byungju Lee; Samuel N Lockhart; Duk L Na; Sang Won Seo
Journal:  Neurology       Date:  2019-08-23       Impact factor: 9.910

7.  Fetuin-A, a new vascular biomarker of cognitive decline in older adults.

Authors:  Gail A Laughlin; Linda K McEvoy; Elizabeth Barrett-Connor; Lori B Daniels; Joachim H Ix
Journal:  Clin Endocrinol (Oxf)       Date:  2014-01-07       Impact factor: 3.478

Review 8.  Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders.

Authors:  Vijay K Ramanan; Andrew J Saykin
Journal:  Am J Neurodegener Dis       Date:  2013-09-18

Review 9.  Brain banking in low and middle-income countries: Raison D'être for the Ibadan Brain Ageing, Dementia And Neurodegeneration (IBADAN) Brain Bank Project.

Authors:  Rufus O Akinyemi; Ayodeji Salami; Joshua Akinyemi; Akin Ojagbemi; Funmi Olopade; Motunrayo Coker; Temitope Farombi; Michael Nweke; Oyedunni Arulogun; Ayodele Jegede; Mayowa Owolabi; Rajesh N Kalaria; Adesola Ogunniyi
Journal:  Brain Res Bull       Date:  2018-08-24       Impact factor: 4.077

10.  Intermittent hypoxia training protects cerebrovascular function in Alzheimer's disease.

Authors:  Eugenia B Manukhina; H Fred Downey; Xiangrong Shi; Robert T Mallet
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.